Leal T, et al. Identifying resistance to immune checkpoint inhibitors by screening for PD-L1 and MHC I expression on CTCS in pts with NSCLC. IASLC 2018; abstract P3.04-08.
Dabrafenib/trametinib bij melanoom na prijsonderhandeling in basispakket
jun 2020 | Dermato-oncologie